Abstract
Depression is the most common psychological disturbance that affects people with Parkinson’s disease (PD). Despite an increasing amount of research devoted to this topic, uncertainty still exists concerning many aspects of depression in PD. Significant questions remain regarding some very basic issues, including how best to diagnose depression in PD, how frequently depression complicates PD, the risk factors for developing depression, and how to best treat depression. This chapter provides a current perspective on what is known about depression in PD, reviewing its epidemiology, clinical features, neuropsychological features, and treatment. Rather than providing a comprehensive overview, the focus here is on updating the major themes of research in this field.
Chapter PDF
Similar content being viewed by others
Key Words
References
Cummings JL. Depression and Parkinson’s disease: a review. Am J Psychiatry 1992;149: 443–454.
Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression inParkinson’s disease. A community-based study. Arch Neurol 1996;53:175–179.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder, 3rd ed. American Psychiatric Association, Washington, DC, 1980.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–389.
Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189–198.
Goldberg DP, William P. A User’s Guide to the General Health Questionnaire. NFER-Nelson, Windsor, 1988.
Hantz P, Caradoc-Davies G, Caradoc-Davies T, et al. Depression in Parkinson’s disease. Am J Psychiatry 1994;151:1010–1014.
Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. Depression in Parkinson’s disease. J Nerv Ment Dis 1990;178:27–31.
Celesia GG, Wanamaker WM. Psychiatric disturbances in Parkinson’s disease. Dis Nerv Syst 1976; 37:123–125.
Brown R, Jahanshahi M. Depression in Parkinson’s disease: a psychosocial viewpoint. Adv Neurol 1995;65:61–84.
Starkstein SE, Berthier ML, Bolduc PL, et al. Depression in patients with early versus late onset Parkinson’s disease. Neurology 1989;39:1441–1445.
Gotham AM, Brown RG, Marsden CD. Depression in Parkinson’s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381–389.
Brown RC, MacCarthy B. Psychiatric morbidity in patients with Parkinson’s disease. Psychol Med 1990;20:77–87.
Huber SJ, Paulson GW, Shuttleworth EC. Depression in Parkinson’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:47–51.
Jankovic J, McDermott M, Carter J, et al. Parkinson Study Group. Variable expression of Parkinson’s disease: a baseline analysis of the DATATOP cohort. Neurology 1990;40:1529–1534.
Brown GL, Wilson WP. Parkinsonism and depression. South Med J 1972;65:540–545.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington, DC, 1994.
Leentjens AFG, Marinus J, Van Hilten JJ, et al. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson’s disease: a discriminant analytic approach. J Neuropsychiatry Clin Neurosci 2003;15:74–77.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
Gonera EG, van’t Hof M, Berger HJ, et al. Symptoms and duration of the prodromal phase in Parkinson’s disease. Mov Disord 1997;12:871–876.
Nilsson FM, Kessing LV, Bolwig TC. Increased risk of developing Parkinson’s disease for patients with major affective disorder-a register study. Acta Psychiatr Scand 2001;104:380–386.
Krishnan KR, Delong M, Kraemer H, et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry 2002;52:559–588.
Nilsson FM, Kessing LV, Sorensen TM, et al. Major depressive disorder in Parkinson’s disease: a register-based study. Acta Psychiatr Scand 2002;106:202–211.
Leentjens AFG, Lousberg R, Verhey FJR. Markers for depression in Parkinson’s disease. Acta Psychiatr Scand 2002;106:196–201.
MacCarthy B, Brown RG. Psychosocial factors in Parkinson’s disease. Br J Clin Psychol 1989; 28:41–52.
Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340:1476–1480.
Alexopoulos G, Kiosses D, Klimstra S, Kalayam B, Bruce M. Clinical presentation of the “depression-executive dysfunction syndrome” of late life. Am J Geriatr Psychiatry 2002;10:98–106.
Oertel WH, Hoglinger GU, Caraceni T, et al. Depression in Parkinson’s disease. Adv Neurol 2001; 86:373–383.
Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson Diseases. Arch Neurol 2003;60:337–341.
Price KS, Farley IJ, Hornykiewicz O. Neurochemistry of Parkinson’s disease: relationbetween striatal and limbic dopamine. Adv Biochem Psychopharmacol 1978;19:293–300.
Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson’s disease? Neurology 1980;30:1326–1330.
Baxter LR, Jr., Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989;46:243–250.
Huber SJ, Bornstein RA. Neuropsychological evaluation of Parkinson’s disease. In: Huber SJ, Cummings JL, eds. Parkinson’s Disease: Neurobehavioral Aspects. Oxford University Press, New York, 1989, pp. 32–45.
desRosiers G. Primary or depressive dementia: Mental status screening. Int J Neurosci 1992;64: 33–67.
LaRue A. Aging and Neuropsychological Assessment. Plenum, New York, 1992, pp. 259–289.
Rosenstein LD. Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: A summary of the literature of the early 1990s. Neuropsychol Rev 1998;8:109–167.
Mahurin RK, Feher EP, Nance ML, et al. Cognition in Parkinson’s disease and related disorders. In: Parks RW, Zec RF, Wilson RS, eds. Neuropsychology of Alzheimer’s Disease and Other Dementias. Oxford University Press, New York, 1993, pp. 308–349.
Levin BE, Katzen HL. Early cognitive changes and nondementing behavioral abnormalities in Parkinson’s disease. Adv Neurol 1995;65:85–95.
Bondi MW, Kaszniak AW, Bayles KA, Vance KT. Contributions of frontal system dysfunction to memory and perceptual abilities in Parkinson’s disease. Neuropsychology 1993;7:89–102.
Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson’s disease on cognitive functioning. J Neuropsychiatry Clin Neurosci 2002;14:31–36.
Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson’s disease: drug-induced psychiatric states. Adv Neurol 1995;65:115–138.
Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson’s disease: a consecutive series of 24 patients. Neurology 2002;59:1427–1429.
Kulisevsky J, Berthier ML, Gironell A, et al. Mania following deep brain stimulation for Parkinson’s disease. Neurology 2002;59:1421–1424.
Mendis T, Suchowersky O, Lang A, Gauthier S. Management of Parkinson’s disease: a review of current and new therapies. Can J Neurol Sci 1999; 26:89–103.
Lieberman A. Managing the neuropsychiatric symptoms of Parkinson’s disease. Neurology 1998; 50:S33–S38.
Poewe W, Seppi K. Treatment options for depression and psychosis in Parkinson’s disease. J Neurol 2001;248(Suppl 3):III12–III21.
Aarsland D, Cummings JL. Depression in Parkinson’s disease. Acta Psychiatr Scand 2002;106: 161–162.
Ceravolo R, Nuti A, Piccinni A, et al. Paroxetine in Parkinson’s disease: effects on motor and depressive symptoms. Neurology 2000;55:1216–1218.
Ritter JL, Alexander B. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature. Ann Clin Psychiatry 1997;9:7–13.
Onofrj M, Luciano AL, Thomas A, et al. Mirtazapine induces REM sleep behavior disorder (RBD) in Parkinsonism. Neurology 2003;60:113–115.
Okun MS, McDonald WM, DeLong MR. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. Arch Neurol 2002;59:807–811.
Burke WJ, Peterson J, Rubin EH. Electroconvulsive therapy in the treatment of combined depression and Parkinson’s disease. Psychosomatics 1988;29:341–346.
Wengel SP, Burke WJ, Pfeiffer RF, et al. Maintenance electroconvulsive therapy for intractable Parkinson’s disease. Am J Geriatr Psychiatry 1998;6:263–269.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Burke, W.J., Wengel, S.P., Bohac, D. (2005). Depression. In: Pfeiffer, R.F., Bodis-Wollner, I. (eds) Parkinson’s Disease and Nonmotor Dysfunction. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-859-5:3
Download citation
DOI: https://doi.org/10.1385/1-59259-859-5:3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-316-9
Online ISBN: 978-1-59259-859-5
eBook Packages: MedicineMedicine (R0)